{"company":{"id":2127750,"name":"MaxCyte","domain":"maxcyte.com","url":"https://alion.io/company/maxcyte"},"section":"news","answer":"MaxCyte: 10 headlines on record, 4 headlines in the last 90 days. Its story counts 5 milestones.","figures":[{"label":"Headlines","value":"10"},{"label":"In 90 days","value":"4"},{"label":"Milestones","value":"5"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":4},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":5}],"news":[{"date":"2026-10-07","kind":"News","title":"MaxCyte stock gained 0.9 percent as revenue fell 15 percent","source":"MaxCyte stock gained 0.9 percent as revenue fell 15 percent","url":"https://ad-hoc-news.de/boerse/news/nebenwerte/maxcyte-stock-gained-0-9-percent-as-revenue-fell-15-percent/70248600"},{"date":"2026-09-24","kind":"News","title":"MaxCyte stock slips 4.03 percent as new chief arrives","source":"MaxCyte stock slips 4.03 percent as new chief arrives","url":"https://ad-hoc-news.de/boerse/news/nebenwerte/maxcyte-stock-slips-4-03-percent-as-new-chief-arrives/70177307"},{"date":"2026-09-23","kind":"News","title":"MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer","source":"markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/maxcyte-appoints-sidharth-kapileshwar-as-chief-corporate-development-officer-1036567171"},{"date":"2026-09-23","kind":"News","title":"MaxCyte stock falls as revenue and market value remain under pressure","source":"MaxCyte stock falls as revenue and market value remain under pressure","url":"https://ad-hoc-news.de/boerse/news/nebenwerte/maxcyte-stock-falls-as-revenue-and-market-value-remain-under-pressure/70164724"}],"story":[{"title":"New executive MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer · markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/maxcyte-appoints-sidharth-kapileshwar-as-chief-corporate-development-officer-1036567171"},{"title":"Team of 108 was 96 · US Form 5500 (plan participants)"},{"title":"Acquisition MaxCyte Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments · Nasdaq","url":"https://nasdaq.com/press-release/maxcyter-acquires-sequre-dx-broaden-cell-engineering-offerings-target-and-target"},{"title":"Raised a round Venture round $760k · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1287098/000128709816000003/"},{"title":"Founded"}],"as_of":"2026-11-20","cite":"MaxCyte, News. Alion, Nov 20, 2026. https://alion.io/company/maxcyte/news","html_url":"https://alion.io/company/maxcyte/news","json_url":"https://alion.io/company/maxcyte/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-20T19:32:46Z"}}